EMU-116
EMU-116 is an orally active CXCR4 antagonist. EMU-116 can be used in the study of cancer[1].
Product Specifications
CAS Number
2241724-59-2
UNSPSC
12352005
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emu-116.html
Purity
98.53
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1CCN(C2=CC=CC3=C2C[C@H](CN(C)[C@H]4CCCC5=C4N=CC=C5)NC3)CC1
Molecular Formula
C25H35N5
Molecular Weight
405.58
References & Citations
[1]Jacobs L, et al. Scale-Up Preparation of Best-In-Class Orally Bioavailable CXCR4 Antagonist EMU-116 in an Academic Setting[J]. Organic Process Research & Development, 2024.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-C178585-10MG 10 mg
N-(2-Carboxy-2-hydroxycaproyl)hydrazobenzene
Sign In for Pricing
View Details 
BNC042148-500 1x 500 µL
Cytokeratin, Basic (Type II or HMW) (rKRTH/2148), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 